Cargando…

Phase I Study of a Combination of Fluvastatin and Celecoxib in Children with Relapsing/Refractory Low-Grade or High-Grade Glioma (FLUVABREX)

SIMPLE SUMMARY: This study tested the repurposing of two rationally selected, non-anticancer drugs as a way to address the need for less toxic therapeutic options in children with gliomas. The determined recommended phase II dose of fluvastatin in combination with celecoxib in children with gliomas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Leblond, Pierre, Tresch-Bruneel, Emmanuelle, Probst, Alicia, Néant, Nadège, Solas, Caroline, Sterin, Arthur, Boulanger, Thomas, Aerts, Isabelle, Faure-Conter, Cécile, Bertozzi, Anne-Isabelle, Chastagner, Pascal, Entz-Werlé, Natacha, De Carli, Emilie, Deley, Marie-Cécile Le, Bouche, Gauthier, André, Nicolas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093481/ https://www.ncbi.nlm.nih.gov/pubmed/37046681 http://dx.doi.org/10.3390/cancers15072020

Ejemplares similares

EPCT-11. PHASE 1 STUDY OF FLUVASTATIN-CELECOXIB COMBINATION IN CHILDREN WITH RELAPSING/REFRACTORY OPTICO-CHIASMATIC LOW-GRADE GLIOMA OR HIGH-GRADE GLIOMAS (FLUVABREX): FINAL RESULTS
por: Andrew, Nicolas, et al.
Publicado: (2020)

Metronomic Four-Drug Regimen Has Anti-tumor Activity in Pediatric Low-Grade Glioma; The Results of a Phase II Clinical Trial
por: Verschuur, Arnauld, et al.
Publicado: (2018)

Evidence for new targets and synergistic effect of metronomic celecoxib/fluvastatin combination in pilocytic astrocytoma
por: Mercurio, Sandy, et al.
Publicado: (2013)

Association between genetic polymorphisms and platinum-induced ototoxicity in children
por: Lui, Gabrielle, et al.
Publicado: (2018)

Impact of Chromatin Dynamics and DNA Repair on Genomic Stability and Treatment Resistance in Pediatric High-Grade Gliomas
por: Pinto, Lia, et al.
Publicado: (2021)

MBCL-29. PHASE I/II STUDY OF SEQUENTIAL HIGH-DOSE CHEMOTHERAPY WITH STEM CELL SUPPORT IN CHILDREN YOUNGER THAN 5 YEARS OF AGE WITH HIGH-RISK MEDULLOBLASTOMA
por: Dufour, Christelle, et al.
Publicado: (2020)

Phase I study of vinblastine in combination with nilotinib in children, adolescents, and young adults with refractory or recurrent low-grade glioma
por: Vairy, Stephanie, et al.
Publicado: (2020)

HGG-36. HIF-2: A NEW DRUG TARGET IN PEDIATRIC HIGH-GRADE GLIOMA WITH PROMISING PRECLINICAL RESULTS
por: Fuchs, Quentin, et al.
Publicado: (2020)

WHO grade has no prognostic value in the pediatric high-grade glioma included in the HERBY trial
por: Varlet, Pascale, et al.
Publicado: (2020)

Gene signature associated with resistance to fluvastatin chemoprevention for breast cancer
por: Bhardwaj, Anjana, et al.
Publicado: (2022)

Efficacy of fluvastatin and aspirin for prevention of hormonally insensitive breast cancer
por: Bhardwaj, Anjana, et al.
Publicado: (2021)

Enantiospecific Pharmacogenomics of Fluvastatin
por: Hirvensalo, Päivi, et al.
Publicado: (2019)

Hypoxia Inducible Factors’ Signaling in Pediatric High-Grade Gliomas: Role, Modelization and Innovative Targeted Approaches
por: Fuchs, Quentin, et al.
Publicado: (2020)

Role of Topoisomerases in Pediatric High Grade Osteosarcomas: TOP2A Gene Is One of the Unique Molecular Biomarkers of Chemoresponse
por: Nguyen, Aurelia, et al.
Publicado: (2013)

HGG-34. A DNA DAMAGE REPAIR SIGNATURE IN PRIMARY AND RECURRENT PEDIATRIC HIGH-GRADE GLIOMAS: PROGNOSTIC AND THERAPEUTIC VALUE
por: Entz-Werle, Natacha, et al.
Publicado: (2021)

Pharmaceutical-grade Chondroitin sulfate is as effective as celecoxib and superior to placebo in symptomatic knee osteoarthritis: the ChONdroitin versus CElecoxib versus Placebo Trial (CONCEPT)
por: Reginster, Jean-Yves, et al.
Publicado: (2017)

The Difference in Pharmacokinetics and Pharmacodynamics between Extended-Release Fluvastatin and Immediate-Release Fluvastatin in Healthy Chinese Subjects
por: Xu, H. R., et al.
Publicado: (2012)

SFCE-RAPIRI Phase I Study of Rapamycin Plus Irinotecan: A New Way to Target Intra-Tumor Hypoxia in Pediatric Refractory Cancers
por: Jannier, Sarah, et al.
Publicado: (2020)

Effects of Fluvastatin on the Pharmacokinetics of Repaglinide: Possible Role of CYP3A4 and P-glycoprotein Inhibition by Fluvastatin
por: Lee, Chong-Ki, et al.
Publicado: (2013)

LGG-16. Retrospective and integrative analyses of molecular characteristics and their specific imaging parameters in pediatric grade 1 gliomas.
por: Courant, Marie, et al.
Publicado: (2022)

Retrospective National “Real Life” Experience of the SFCE with the Metronomic MEMMAT and MEMMAT-like Protocol
por: Winnicki, Camille, et al.
Publicado: (2023)

Prognostic and predictive factors for angiosarcoma patients receiving paclitaxel once weekly plus or minus bevacizumab: an ancillary study derived from a randomized clinical trial
por: Lebellec, Loïc, et al.
Publicado: (2018)

Kinetic Spectrophotometric Determination of Fluvastatin in Pharmaceutical Preparations
por: Ashour, Safwan, et al.
Publicado: (2010)

Radiosurgery for high-grade glioma
por: Binello, Emanuela, et al.
Publicado: (2012)

Together Intra-Tumor Hypoxia and Macrophagic Immunity Are Driven Worst Outcome in Pediatric High-Grade Osteosarcomas
por: Nazon, Charlotte, et al.
Publicado: (2022)

Prognostic impact of blood and urinary angiogenic factor levels at diagnosis and during treatment in patients with osteosarcoma: a prospective study
por: Tabone, Marie-Dominique, et al.
Publicado: (2017)

MEDB-84. The French experience of ELP1-related medulloblastomas
por: Tauziède-Espariat, Arnault, et al.
Publicado: (2022)

A DNA Repair and Cell Cycle Gene Expression Signature in Pediatric High-Grade Gliomas: Prognostic and Therapeutic Value
por: Entz-Werlé, Natacha, et al.
Publicado: (2021)

Inhibition of Candida albicans by Fluvastatin Is Dependent on pH
por: Schmidt, Martin, et al.
Publicado: (2009)

Improvement of fluvastatin bioavailability by loading on nanostructured lipid carriers
por: El-Helw, Abdel-Rahim M, et al.
Publicado: (2015)

The calcium: an early signal that initiates the formation of the nervous system during embryogenesis
por: Leclerc, Catherine, et al.
Publicado: (2012)

Association of carcinoid tumor and low grade glioma
por: Tabouret, Emeline, et al.
Publicado: (2012)

Characterization of the transcriptional and metabolic responses of pediatric high grade gliomas to mTOR-HIF-1α axis inhibition
por: Nguyen, Aurélia, et al.
Publicado: (2017)

Fluvastatin protects cochleae from damage by high-level noise
por: Richter, Claus-Peter, et al.
Publicado: (2018)

Enhanced oral bioavailability of fluvastatin by using nanosuspensions containing cyclodextrin
por: Li, Jun, et al.
Publicado: (2018)

Synergistic anti-tumor efficacy of sorafenib and fluvastatin in hepatocellular carcinoma
por: Cheng, Yang, et al.
Publicado: (2017)

Fluvastatin Prevents Lung Adenocarcinoma Bone Metastasis by Triggering Autophagy
por: Yang, Zuozhang, et al.
Publicado: (2017)

Fluvastatin Sodium Ameliorates Obesity through Brown Fat Activation
por: Yin, Na, et al.
Publicado: (2019)

Preventive effect of fluvastatin on the development of medication-related osteonecrosis of the jaw
por: Adachi, Naomi, et al.
Publicado: (2020)

Fluvastatin potentiates anticancer activity of vorinostat in renal cancer cells
por: Okubo, Kazuki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t3kl79vblcq8aq2mvgjqaspkq6